DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Boellner SW, Stark JG, Krishnan S et al.
Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study.
Clin Ther 2010;
32: 252-264
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.